Redeye Ab

Redeye Ab company information, Employees & Contact Information

Explore related pages

Related company profiles:

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors. Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Company Details

Employees
82
Founded
-
Address
Mäster Samuelsgatan 42, Stockholm,sweden
Phone
+46 8 54 50 13 30
Email
in****@****deye.se
Industry
Financial Services
NAICS
Finance and Insurance
Monetary Authorities-Central Bank
Website
redeye.se
HQ
Stockholm
Looking for a particular Redeye Ab employee's phone or email?

Redeye Ab Questions

News

Redeye: Xvivo Perfusion - And the beat goes on - TradingView

Redeye: Xvivo Perfusion - And the beat goes on TradingView

Invitation to Presentations of Senzime's Third Quarter 2025 Report - ACCESS Newswire

Invitation to Presentations of Senzime's Third Quarter 2025 Report ACCESS Newswire

Redeye: MedCap (Q3 review) - Healthy Q3 figures - TradingView

Redeye: MedCap (Q3 review) - Healthy Q3 figures TradingView

IRLAB to Present at Redeye Theme: Neurology - PharmiWeb.com

IRLAB to Present at Redeye Theme: Neurology PharmiWeb.com

Redeye: AVTECH (Q3 Review) - Medium-term upside recognised - TradingView

Redeye: AVTECH (Q3 Review) - Medium-term upside recognised TradingView

Redeye: Litium (Q3 Review) - Profit Added to Cart - TradingView

Redeye: Litium (Q3 Review) - Profit Added to Cart TradingView

Redeye: Dynavox Group (Q3 review) - Strong momentum continues, solid results and positive outlook ahead - TradingView

Redeye: Dynavox Group (Q3 review) - Strong momentum continues, solid results and positive outlook ahead TradingView

Redeye: Enea (Q3 Review) - Growth needed to escape the doldrums - TradingView

Redeye: Enea (Q3 Review) - Growth needed to escape the doldrums TradingView

Redeye: Vitec (Q3 review) - Starting to look at 2026e - TradingView

Redeye: Vitec (Q3 review) - Starting to look at 2026e TradingView

Redeye: Xspray Pharma - Update after Dasynoc CRL - TradingView

Redeye: Xspray Pharma - Update after Dasynoc CRL TradingView

Invitation: Gapwaves Q3 2025 Presentation - TradingView

Invitation: Gapwaves Q3 2025 Presentation TradingView

Jumpgate: Interview with CEO Harald Riegler - TradingView

Jumpgate: Interview with CEO Harald Riegler TradingView

Redeye: Absolent - Continued market headwinds - TradingView

Redeye: Absolent - Continued market headwinds TradingView

Redeye: Camurus Q2 2025 - Deal with Eli Lilly - TradingView

Redeye: Camurus Q2 2025 - Deal with Eli Lilly TradingView

Redeye: OXE Marine - Solid execution - TradingView

Redeye: OXE Marine - Solid execution TradingView

Redeye: Eniro Group - Cutting costs - TradingView

Redeye: Eniro Group - Cutting costs TradingView

Redeye: Tradedoubler - One eye on growth, one eye on AI - TradingView

Redeye: Tradedoubler - One eye on growth, one eye on AI TradingView

Redeye: Acconeer - H2 2025 critical for confidence in targets - TradingView

Redeye: Acconeer - H2 2025 critical for confidence in targets TradingView

Redeye: Waystream - Continues the good run - TradingView

Redeye: Waystream - Continues the good run TradingView

Redeye: Verve Group - Increased market uncertainty - TradingView

Redeye: Verve Group - Increased market uncertainty TradingView

Redeye: Redeye Initiates Coverage of Xplora Technologies - TradingView

Redeye: Redeye Initiates Coverage of Xplora Technologies TradingView

Redeye: Xbrane Biopharma Q1 2025 - Transformative times - TradingView

Redeye: Xbrane Biopharma Q1 2025 - Transformative times TradingView

Redeye: Truecaller - A stable quarter in uncertain times - TradingView

Redeye: Truecaller - A stable quarter in uncertain times TradingView

Redeye: Addnode - Rebound in PLM - TradingView

Redeye: Addnode - Rebound in PLM TradingView

Redeye: W5 Solutions - Order intake remains solid - TradingView

Redeye: W5 Solutions - Order intake remains solid TradingView

Southwest Airlines now has redeye flights: See the routes - LiveNOW from FOX

Southwest Airlines now has redeye flights: See the routes LiveNOW from FOX

Redeye: Episurf Medical Q2 2025 - Negative impact due to ongoing restructuring - Finansavisen

Redeye: Episurf Medical Q2 2025 - Negative impact due to ongoing restructuring Finansavisen

Redeye: Carasent (Q3 Review) - In good shape for exciting 2026 - TradingView

Redeye: Carasent (Q3 Review) - In good shape for exciting 2026 TradingView

Redeye: CombinedX (Q3 Review) - Mergers and acquisitions paying off - TradingView

Redeye: CombinedX (Q3 Review) - Mergers and acquisitions paying off TradingView

Redeye: Momentum Group (Q3 Review) – No drama - TradingView

Redeye: Momentum Group (Q3 Review) – No drama TradingView

Redeye: Lagercrantz (Q2 review) - Strong M&A pipeline - TradingView

Redeye: Lagercrantz (Q2 review) - Strong M&A pipeline TradingView

Redeye: Polygiene Group (Q3 Review) - Recovery in Sight - TradingView

Redeye: Polygiene Group (Q3 Review) - Recovery in Sight TradingView

Redeye: BONESUPPORT (Q3 Review) - Still just getting started - TradingView

Redeye: BONESUPPORT (Q3 Review) - Still just getting started TradingView

Redeye: Relais (Q3 review) - Solid adjusted EBITA and organic growth - TradingView

Redeye: Relais (Q3 review) - Solid adjusted EBITA and organic growth TradingView

Redeye: SSH (Q3 Review) - Growth Authenticated - TradingView

Redeye: SSH (Q3 Review) - Growth Authenticated TradingView

Redeye: Invisio (Q3 Review) - Positioned for a strong year-end - TradingView

Redeye: Invisio (Q3 Review) - Positioned for a strong year-end TradingView

Redeye: Stille (Q3 update) - Prolonged headwind but valuation remains undemanding - TradingView

Redeye: Stille (Q3 update) - Prolonged headwind but valuation remains undemanding TradingView

Redeye: Waystream - Continues the beaten track - TradingView

Redeye: Waystream - Continues the beaten track TradingView

Redeye: Safeture (Q3 Review) - The ARR Strikes Back - TradingView

Redeye: Safeture (Q3 Review) - The ARR Strikes Back TradingView

Redeye: Cheffelo - Takeaways from CMD and updated valuation - TradingView

Redeye: Cheffelo - Takeaways from CMD and updated valuation TradingView

Redeye: Vertiseit (Q3 Review) - Promising outlook and retail media momentum - TradingView

Redeye: Vertiseit (Q3 Review) - Promising outlook and retail media momentum TradingView

Redeye: Lifco (Q3 review) - The flywheel keeps spinning - TradingView

Redeye: Lifco (Q3 review) - The flywheel keeps spinning TradingView

Redeye: Evolution (Q3 Review) - Asia uncertainty returns - TradingView

Redeye: Evolution (Q3 Review) - Asia uncertainty returns TradingView

Redeye: Hexatronic (Q3 Review) - Data Center taking the lead - TradingView

Redeye: Hexatronic (Q3 Review) - Data Center taking the lead TradingView

Redeye: Sdiptech (Q3 Review) - Stable core becoming increasingly visible - TradingView

Redeye: Sdiptech (Q3 Review) - Stable core becoming increasingly visible TradingView

Redeye: Powercell - Making progress in multiple areas - TradingView

Redeye: Powercell - Making progress in multiple areas TradingView

Redeye: Invisio - Positive outlook and raised profitability target - TradingView

Redeye: Invisio - Positive outlook and raised profitability target TradingView

Redeye: BONESUPPORT Q2 - Still puttin’ on the ritz - TradingView

Redeye: BONESUPPORT Q2 - Still puttin’ on the ritz TradingView

Redeye: CTEK - A minor bump in the road - TradingView

Redeye: CTEK - A minor bump in the road TradingView

Redeye: CTEK - A CMD that underpins the new financial targets - TradingView

Redeye: CTEK - A CMD that underpins the new financial targets TradingView

Redeye: SSH Communications Security - Time to deliver - TradingView

Redeye: SSH Communications Security - Time to deliver TradingView

Redeye: Polygiene - Retake – Scalability in Focus - TradingView

Redeye: Polygiene - Retake – Scalability in Focus TradingView

Redeye: Avensia - Stable performance in soft market - TradingView

Redeye: Avensia - Stable performance in soft market TradingView

Redeye: Sivers Semiconductors - One design, many customers - TradingView

Redeye: Sivers Semiconductors - One design, many customers TradingView

Redeye: Devyser Q2 - Profitable from here on - TradingView

Redeye: Devyser Q2 - Profitable from here on TradingView

Redeye: Systemair - Firm margins despite soft top-line - TradingView

Redeye: Systemair - Firm margins despite soft top-line TradingView

Redeye: Lifco Q2 2025 - Short-term pain - TradingView

Redeye: Lifco Q2 2025 - Short-term pain TradingView

Redeye: Vitec Q2 2025 - Stormy waters, smoother sailing ahead - TradingView

Redeye: Vitec Q2 2025 - Stormy waters, smoother sailing ahead TradingView

Redeye: Mendus - Expanding vididencel’s market potential - TradingView

Redeye: Mendus - Expanding vididencel’s market potential TradingView

Redeye: Serstech - Stronger organisation, weaker market - TradingView

Redeye: Serstech - Stronger organisation, weaker market TradingView

Redeye: Lime - Breakthrough among German utilities - TradingView

Redeye: Lime - Breakthrough among German utilities TradingView

Redeye: NextCell Pharma Q3 2024/2025 - Largely as expected - TradingView

Redeye: NextCell Pharma Q3 2024/2025 - Largely as expected TradingView

Redeye: Nekkar - Q1 Review – Short-Term Softness, Fundamentals Intact - TradingView

Redeye: Nekkar - Q1 Review – Short-Term Softness, Fundamentals Intact TradingView

Dodge Unveils The Sixth Edition Of It’s “Last Call” Series, The ‘Black Ghost’! - MoparInsiders

Dodge Unveils The Sixth Edition Of It’s “Last Call” Series, The ‘Black Ghost’! MoparInsiders

Dignitana appoints Catarina Mård Löwenadler as CEO - Cision News

Dignitana appoints Catarina Mård Löwenadler as CEO Cision News

Scandinavian ChemoTech foresees higher future revenues after signing a third commercial contract in India - Cision News

Scandinavian ChemoTech foresees higher future revenues after signing a third commercial contract in India Cision News

Cancer leader City of Hope selects DigniCap for community network in California - Cision News

Cancer leader City of Hope selects DigniCap for community network in California Cision News

Atari Grants Licensing Rights to Build Atari Hotels in the U.S. - Licensing International

Atari Grants Licensing Rights to Build Atari Hotels in the U.S. Licensing International

Hans Naess Appointed New CFO of Heliospectra AB - Cision News

Hans Naess Appointed New CFO of Heliospectra AB Cision News

Red Eye Panel Tackles S.E. Cupp Hustler Controversy: Why Can’t She Sue? - mediaite.com

Red Eye Panel Tackles S.E. Cupp Hustler Controversy: Why Can’t She Sue? mediaite.com

Top Redeye Ab Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant